It's thanks to these medications--a cocktail built around the antiviral drug zidovudine, also called AZT--that rates of so-called perinatal transmission of HIV are so low in some parts of the world. In the U.S., fewer than 100 HIV-positive babies were diagnosed in 2015, representing a remarkable success story in the history of an epidemic that has killed 35 million.